A detailed history of Graham Capital Management, L.P. transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 19,773 shares of FDMT stock, worth $157,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,773
Previous 14,649 34.98%
Holding current value
$157,986
Previous $307,000 30.62%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.81 - $27.22 $55,390 - $139,475
5,124 Added 34.98%
19,773 $213,000
Q2 2024

Aug 14, 2024

BUY
$20.93 - $30.01 $306,603 - $439,616
14,649 New
14,649 $307,000

Others Institutions Holding FDMT

About 4D Molecular Therapeutics, Inc.


  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $259M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.